Ontario cannabis producers will soon be allowed to sell their pot directly to consumers. But there is a BIG catch.
Articles
U.S. approves first prescription drug made from MJ
U.S. health regulators on Monday approved the first prescription drug made from marijuana, a milestone that could spur more research into a drug that remains illegal under federal law, despite growing legalization for recreational and medical use.
China Must Import More Hemp From U.S. Under New Trade Deal
After years of being one of the United States’s main sources of hemp imports, China will now be required to buy a lot more of the non-intoxicating cannabis crop from the U.S. under a new trade deal.
Federal Agency Wants Public’s Help Finding Research On Medical MJ For Pain And Migraines
A federal agency is asking the public to submit scientific data on the potential benefits of marijuana for people with acute pain and migraine headaches.
Is CBD ‘Harmful’ to Our Liver? No.
The U.S. Food and Drug Administration is claiming that CBD poses significant risks to the human liver. Nonsense.
Marijuana Record Expungement Movement Growing Rapidly, Report Shows
Though eleven states and Washington, D.C. have legalized recreational marijuana, the process of expunging prior cannabis convictions remains complicated and expensive, with methods to clear records varying widely between jurisdictions.
The entourage effect: How compounds may be working together
Take a close look at your cannabis buds. They’re covered in sticky, shining dots of resin, and in this resin are hundreds of therapeutic compounds that contribute to the effects and benefits of cannabis.
Not All Terpenes Are Made Equal: Knowing the Difference
Terpenes are aromatic hydrocarbons that help make up the smell found in the essential oils of certain plants like cannabis. Ten years ago, the word meant nothing to the average cannabis consumer. Now, it is one of the most cherished aspects of the plant. In fact, a study on terpenes showed that the smell of a strain influenced people’s perception of the value and potency when compared to others.
Anti-Cannabis Fiction Stokes Quebec Government Paranoia
Quebec's provincial government suffers from acute anti-cannabis paranoia. Chicken Little pseudo-science like this doesn't help.
This Week in Cannabis Investing January 17th
This is The Seed Investor's weekly wrap up of major news from the cannabis industry and our analysis of the important trends.
Joe Biden Again Says No To MJ Legalization Without More Studies
Former Vice President Joe Biden reaffirmed that he’s opposed to legalizing marijuana without further studying its potential health risks.
Weed and weight: Why are cannabis consumers slimmer?
Diet. Detox. Paleo. Parisian. Whatever you want to call it, nearly half of Canadians are following some sort of food plan to lose weight, according to a recent national poll.
Industry Leaders Leading Turnaround in Marijuana Stocks?
The largest U.S.-based cannabis company and the largest Canadian cannabis company have both seen their stock make strong moves. Will other cannabis companies follow?
Organigram Beats in Fiscal Q1, Stock Soars, But For How Long?
Organigram Holdings was sharply higher yesterday after reporting its fiscal Q1 2020. But with negligible revenue growth over the past two quarters, is that gain sustainable?
Bigger isn’t better: The case for growing small plants
We’re not going to delve into other matters where this might be up for debate, but when it comes to cannabis, bigger doesn’t mean better.